|
Measurement tools / ALS clinic
Erin Singleton
(25 Mar 2015 15:13 EDT)
|
|
RE: Measurement tools / ALS clinic
Gizzi, Nancy
(25 Mar 2015 17:13 EDT)
|
|
RE: Measurement tools / ALS clinic Amy Roman (26 Mar 2015 15:19 EDT)
|
|
RE: COMMERCIAL:RE: Measurement tools / ALS clinic
Helen Paterson
(27 Mar 2015 03:31 EDT)
|
Hi Erin,
I think an important measurement is speech rate. This has clinical implications based on the Ball, Willis, Beukelman, and Yorkston research as you know. I don't like using speech NOMs because they don't show all the benefits from our interventions (they measure "speech" which is declining but not functional communication which we can improve). As you know, I use the ALS Functional Communication Scale to develop my severity measures for G-coding. I just made a Communication Checklist for patients so they can jot down their challenges in the 7 functional communication areas.
Here is the patient friendly checklist http://amyandpals.com/pdf-test/.
and the AFC Scale for professionals is at http://amyandpals.com/als-communication-scale/
Here is a review article that talks about the speech rate. http://www.asha.org/Publications/leader/2004/041214/f041214a1.htm
Sincerely,
Amy Roman, MS, CCC-SLP
Augmentative Communication Specialist
AmyandpALS.Com
Pinterest.com/AmyandPALS
Forbes Norris ALS Research and Treatment Center
2324 Sacramento Street
San Francisco, CA 94115
Cell (415)518-0592
Fax (415)600-3778
--------------------------------------------
On Wed, 3/25/15, Gizzi, Nancy <xxxxxx@leememorial.org> wrote:
Subject: RE: Measurement tools / ALS clinic
To: "xxxxxx@alsa.simplelists.com" <xxxxxx@alsa.simplelists.com>
Date: Wednesday, March 25, 2015, 2:13 PM
#yiv3368793637
#yiv3368793637 --
_filtered #yiv3368793637 {font-family:Calibri;panose-1:2 15
5 2 2 2 4 3 2 4;}
_filtered #yiv3368793637 {font-family:Tahoma;panose-1:2 11
6 4 3 5 4 4 2 4;}
_filtered #yiv3368793637 {panose-1:3 4 6 2 4 6 7 8 9 4;}
#yiv3368793637
#yiv3368793637 p.yiv3368793637MsoNormal, #yiv3368793637
li.yiv3368793637MsoNormal, #yiv3368793637
div.yiv3368793637MsoNormal
{margin:0in;margin-bottom:.0001pt;font-size:11.0pt;}
#yiv3368793637 a:link, #yiv3368793637
span.yiv3368793637MsoHyperlink
{color:blue;text-decoration:underline;}
#yiv3368793637 a:visited, #yiv3368793637
span.yiv3368793637MsoHyperlinkFollowed
{color:purple;text-decoration:underline;}
#yiv3368793637 span.yiv3368793637EmailStyle17
{color:windowtext;}
#yiv3368793637 span.yiv3368793637EmailStyle18
{color:#1F497D;}
#yiv3368793637 .yiv3368793637MsoChpDefault
{font-size:10.0pt;}
_filtered #yiv3368793637 {margin:1.0in 1.0in 1.0in 1.0in;}
#yiv3368793637 div.yiv3368793637WordSection1
{}
#yiv3368793637
We rate the patients according to the
NOMS, generally speech, voice, and swallowing – at times
– AAC - after we do our assessment.
Nancy Gizzi, M.S., C.C.C.
Speech-Language Pathology
Lee Sports Medicine & Rehabilitation, Cape Coral
Hospital
Lee Memorial Health System
xxxxxx@leememorial.org
TEL 239-424-3572
FAX 239-424-4035
From: xxxxxx@alsa.simplelists.com
[mailto:xxxxxx@alsa.simplelists.com]
On Behalf Of Erin Singleton
Sent: Wednesday, March 25, 2015 3:12 PM
To: xxxxxx@alsa.simplelists.com
Subject: Measurement tools / ALS clinic
Good afternoon,
I am wondering if any of
the therapists on this list may be able to share with me
your outcome measurement tools you use in ALS or MDA clinic.
Any scales or patient/caregiver self-evaluation tools would
work as well. Anything pertaining
to speech, swallowing or cognition targeted towards our
neuromuscular population. I am working on a PI project with
our clinic and would love input from others! Thanks in
advance. My email is
xxxxxx@communitymedical.org
Erin
Erin Singleton M.A.,
CCC-SLP
Neuroscience Outpatient
Rehabilitation Center
2335 East Kashian Lane,
Suite 301
Fresno, California
93701
Office: (559)
459-6056
Fax: (559) 459-2957
Email:
xxxxxx@communitymedical.org
-------------------------------------------------------
WARNING/CONFIDENTIAL:
-------------------------------------------------------
This email, including attachments, may contain information
that is privileged, confidential, and/or exempt from
disclosure under applicable law (including, but not limited
to, protected health information). It is not intended for
transmission to, or receipt
by, any unauthorized persons. If the reader of this message
is not the intended recipient you are hereby notified that
any dissemination, distribution or copying of this
communication is strictly prohibited. If you believe this
email was sent to you in error,
do not read it. Reply to the sender informing them of the
error and then destroy all copies and attachments of the
message from your system. Thank you.